- Home
- ETWO vs PHAR Comparison
ETWO vs PHAR Comparison
Compare ETWO & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETWO
- PHAR
- Stock Information
- Founded
- ETWO 2000
- PHAR 1988
- Country
- ETWO United States
- PHAR Netherlands
- Employees
- ETWO N/A
- PHAR N/A
- Industry
- ETWO EDP Services
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- ETWO Technology
- PHAR Health Care
- Exchange
- ETWO Nasdaq
- PHAR Nasdaq
- Market Cap
- ETWO 621.8M
- PHAR 587.5M
- IPO Year
- ETWO N/A
- PHAR N/A
- Fundamental
- Price
- ETWO $1.87
- PHAR $7.80
- Analyst Decision
- ETWO Sell
- PHAR Strong Buy
- Analyst Count
- ETWO 4
- PHAR 3
- Target Price
- ETWO $3.13
- PHAR $30.00
- AVG Volume (30 Days)
- ETWO 935.7K
- PHAR 6.8K
- Earning Date
- ETWO 04-29-2025
- PHAR 03-13-2025
- Dividend Yield
- ETWO N/A
- PHAR N/A
- EPS Growth
- ETWO N/A
- PHAR N/A
- EPS
- ETWO N/A
- PHAR N/A
- Revenue
- ETWO $613,459,000.00
- PHAR $297,200,000.00
- Revenue This Year
- ETWO N/A
- PHAR $8.26
- Revenue Next Year
- ETWO $1.84
- PHAR $9.73
- P/E Ratio
- ETWO N/A
- PHAR N/A
- Revenue Growth
- ETWO N/A
- PHAR 21.15
- 52 Week Low
- ETWO $1.86
- PHAR $6.65
- 52 Week High
- ETWO $5.08
- PHAR $11.30
- Technical
- Relative Strength Index (RSI)
- ETWO 28.40
- PHAR 34.92
- Support Level
- ETWO $1.95
- PHAR $8.03
- Resistance Level
- ETWO $2.09
- PHAR $8.70
- Average True Range (ATR)
- ETWO 0.12
- PHAR 0.32
- MACD
- ETWO -0.03
- PHAR -0.07
- Stochastic Oscillator
- ETWO 1.41
- PHAR 0.00
About ETWO E2open Parent Holdings Inc.Class A
E2open Parent Holdings Inc is an end-to-end and cloud-based supply chain management SaaS platform. The company's software combines networks, data, and applications to provide a deeply embedded, mission-critical platform that allows customers to optimize the supply chain across channel shaping, business planning, logistics, trade, manufacturing, and supply management. The Group has one reportable segment consisting of cloud-based, end-to-end SCM software. Geographically, the company operates in the Americas, Europe, and Asia Pacific, out of which the majority is from the Americas.
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.